Glial cytoplasmic inclusions (GCIs) represent the defining pathological hallmark of Multiple System Atrophy (MSA), distinguishing it from other α-synucleinopathies like Parkinson's disease (PD) and Dementia with Lewy Bodies (DLB). Unlike PD/DLB where α-synuclein aggregates primarily in neurons, MSA features predominant α-synuclein pathology in oligodendrocytes—the myelin-producing cells that support axons in the central nervous system. This oligodendroglial α-synucleinopathy underlies the rapidly progressive nature of MSA and its poor therapeutic response. [@pr漫步2022][@aoki2023]
GCI Pathogenesis
GCI Formation Mechanism
GCIs are silver-positive, eosinophilic inclusions composed primarily of aggregated α-synuclein filaments co-assembled with phosphorylated α-synuclein, tau, and other neurodegenerative-associated proteins including p25α (TPPP/p25α), a brain-specific phosphoprotein enriched in oligodendrocytes. The sequential model of GCI formation involves:
α-Synuclein overexpression in oligodendrocytes driven by dysregulated SNCA expression
Misfolding and nucleation of α-synuclein into oligomeric intermediates
Filament assembly into phosphorylated τ-positive fibrils
GCI maturation with recruitment of myelin proteins and cytoskeletal elements
Oligodendrocyte dysfunction leading to myelin maintenance failure
...
MSA Alpha-Synuclein Glial Cytoplasmic Inclusions
Overview
Glial cytoplasmic inclusions (GCIs) represent the defining pathological hallmark of Multiple System Atrophy (MSA), distinguishing it from other α-synucleinopathies like Parkinson's disease (PD) and Dementia with Lewy Bodies (DLB). Unlike PD/DLB where α-synuclein aggregates primarily in neurons, MSA features predominant α-synuclein pathology in oligodendrocytes—the myelin-producing cells that support axons in the central nervous system. This oligodendroglial α-synucleinopathy underlies the rapidly progressive nature of MSA and its poor therapeutic response. [@pr漫步2022][@aoki2023]
GCI Pathogenesis
GCI Formation Mechanism
GCIs are silver-positive, eosinophilic inclusions composed primarily of aggregated α-synuclein filaments co-assembled with phosphorylated α-synuclein, tau, and other neurodegenerative-associated proteins including p25α (TPPP/p25α), a brain-specific phosphoprotein enriched in oligodendrocytes. The sequential model of GCI formation involves:
α-Synuclein overexpression in oligodendrocytes driven by dysregulated SNCA expression
Misfolding and nucleation of α-synuclein into oligomeric intermediates
Filament assembly into phosphorylated τ-positive fibrils
GCI maturation with recruitment of myelin proteins and cytoskeletal elements
Oligodendrocyte dysfunction leading to myelin maintenance failure
Mermaid diagram (expand to render)
Oligodendrocyte-Specific Factors
The targeting of oligodendrocytes rather than neurons in MSA reflects several oligodendrocyte-specific factors:
While SNCA point mutations cause familial PD, duplications and triplications of the SNCA gene have been linked to MSA cases, supporting a dose-dependent relationship between α-synuclein expression and oligodendrocyte pathology. [@kiyosawa2019] Studies show:
SNCA duplication carriers: Develop MSA phenotype with prominent GCI pathology
SNCA triplication carriers: Earlier onset and more severe disease
SNCA expression in oligodendrocytes: Driven by oligodendrocyte-specific promoters (PLP1, MBP)
Transcriptional Dysregulation
Multiple mechanisms drive SNCA overexpression in MSA oligodendrocytes:
Epigenetic changes: Decreased DNA methylation at SNCA promoter